Skip to content ↓

Input sought on decision-making process on merger of ocean engineering with mechanical engineering

A committee chaired by Professor Steven Tannenbaum, Underwood-Prescott Professor of Toxicology and Professor of Chemistry, is seeking input on a possible merger of Ocean Engineering with Mechanical Engineering.

The committee was formed to review the process and procedures leading up to the merger, in keeping with Section 1.4 of Policies and Procedures. The goal of the committee is to determine whether the process followed in arriving at the proposed reorganization was adequately consultative and appropriately considered, whether it addressed the interests of affected faculty, students, and staff, and whether the individuals affected have had adequate opportunities to make their views known to the decision-makers.

President Vest appointed the committee in consultation with Rafael Bras, Chair of the Faculty, and has asked the committee to report to him by October 15. Anyone affected by the proposed merger who has not yet been contacted and who would like to comment on the fairness of the process may call or write Professor Tannenbaum (253-3729, srt@mit.edu), or one of the other panel members: Professor Edward Boyle of EAPS (x3-3388, eaboyle@mit.edu) or Professor Ian Hutchinson of Nuclear Engineering (253-8760, ihutch@mit.edu).

A version of this article appeared in MIT Tech Talk on September 15, 2004 (download PDF).

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story